Thursday

1st Dec 2022

'Historic day' as EU patent deal ends 40-year wait

  • Atomium - Brussels' signature monument to scientific research (Photo: O Palsson)

The 40-year-long quest to create a single European patent ended on Tuesday (11 December) when the European Parliament ratified a deal which will come into force in 2014.

Speaking in the assembly in Strasbourg, EU single market commissioner Michel Barnier said that the achievement marked a "historic day."

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

Under the regime, inventors will be able to apply to the European Patent Office for a patent valid in 25 of the bloc's 27 member states.

Spain and Italy will remain outside the scope of the patent regime in protest that patents will only be available in English, French or German-language versions.

The three legislative files on the unitary patent, language regime and unified patent court, were each backed by wide majorities with over 480 MEPs in favour.

Supporters of a unitary patent claim that it will drastically reduce costs for businesses and entrepreneurs. Europe-wide patents currently cost around €35,000 each, according to the European Patent Office (EPO), almost 10 times the cost in the US. The European Commission says that EU patent costs could fall to €4,725.

However, the Green group broke ranks in opposing the deal, describing its validity as "legally uncertain" and criticising the status of the EPO and its European Patent Court, which is to exist outside the EU treaty framework.

Christian Engstrom - the Swedish Pirate party deputy and the group's spokesman on intellectual property rights - said the proposal "hands control over European innovation policy to patent lawyers with vested interests, and not the democratically elected legislators."

MEPs had previously demanded that the Luxembourg-based European Court of Justice (ECJ), which acts as arbiter on the application of EU law, should always be the first port of call for patent disputes, but now the patent court will play that role instead.

They had also criticised moves made in July by ministers to strip Articles 6 to 8 out of the patent law, which covered the right for patent holders to prevent the use of their invention for some applications and to put other limitations on their patents.

Speaking at a press conference after the vote, German centre-left MEP, Bernhard Rapkay, admitted that the deal was "a sub-optimal solution."

He added that MEPs had come under intense pressure from lobbyists to veto the deal in the weeks leading up to the vote.

Meanwhile, parliament legal Affairs committee chair Klaus Hehne Lehne told reporters that the rules would strengthen the EU's hand when negotiating on patent rules with China.

"We have closed an important gap in the single market," added the German centre-right deputy.

For his part, Jonathan Zuck, President of the Association for Competitive Technology, said the new system would "remove a major hurdle to innovation and growth" by protecting small businesses form "fragmented national legislation."

Angry MEPs postpone patent vote

Just days after being hailed as solved, the EU decades-long quest for a single patent hit an unexpected snag on Monday evening when MEPs postponed a vote on the draft patent claiming member states had "emasculated" the proposal.

British MPs demand London court to counter EU patent costs

MPs on the UK's House of Commons European Scrutiny committee have demanded that the new EU patent court be based in London in order to mitigate against what it described as "the most damaging effects of a unitary EU-wide patent".

Opinion

Intellectual property protection - the cure for Europe's ills

The European Commission is considering rolling back medical research incentives, on the faulty assumption they are somehow driving higher drug prices. But not only is that premise flawed – the proposed fix will do nothing to benefit ordinary health consumers.

Opinion

Why are our medicines so expensive?

The EU should be promoting open innovation in upcoming trade talks with India and should work to bring down the prices of essential medicines, both abroad and within its borders.

Portugal was poised to scrap 'Golden Visas' - why didn't it?

Over the last 10 years, Portugal has given 1,470 golden visas to people originating from countries whose tax-transparency practices the EU finds problematic. But unlike common practice in other EU states with similar programmes, Portugal has not implemented "due diligence".

Catalan spyware victims demand justice

Victims of the widening spyware scandal in Spain are demanding justice and reparations, following the revelations that journalists, lawyers, civil society and politicians had been targeted.

Stakeholders' Highlights

  1. Nordic Council of MinistersCOP27: Food systems transformation for climate action
  2. Nordic Council of MinistersThe Nordic Region and the African Union urge the COP27 to talk about gender equality
  3. International Sustainable Finance CentreJoin CEE Sustainable Finance Summit, 15 – 19 May 2023, high-level event for finance & business
  4. Friedrich Naumann Foundation European DialogueGender x Geopolitics: Shaping an Inclusive Foreign Security Policy for Europe
  5. Obama FoundationThe Obama Foundation Opens Applications for its Leaders Program in Europe
  6. EFBWW – EFBH – FETBBA lot more needs to be done to better protect construction workers from asbestos

Latest News

  1. Belarus dictator's family loves EU luxuries, flight data shows
  2. How Berlin and Paris sold-out the EU corporate due diligence law
  3. Turkey's EU-funded detention centres ripe with abuse: NGO
  4. In green subsidy race, EU should not imitate US
  5. EU Commission proposes suspending billions to Hungary
  6. EU: Russian assets to be returned in case of peace treaty
  7. Frontex leadership candidates grilled by MEPs
  8. Portugal was poised to scrap 'Golden Visas' - why didn't it?

Join EUobserver

Support quality EU news

Join us